– August 1, 2007
August 1, 2007
View Issues
-
Prostate Cancer with Bone Metastases at Presentation: Current Patterns of Care and Outcomes
Using the CaPSURE registry, clinical features and prognostic factors were identified for the small percentage of patients who have bony metastases at the time of initial presentation. -
Adjuvant Imatinib for GIST: Promising
Imatinib mesylate has proven effective in the management of advanced gastrointestinal stromal tumors, but its use in the adjuvant setting is yet to be established. -
Progression Risk for Smoldering Myeloma
Information on prognostic factors and progression rates from smoldering (ie, asymptomatic) myeloma to multiple myeloma and amyloidosis are limited. -
Prognostic Importance of Leukocytosis in P Vera
In a review of the Mayo Clinic experience over 50 years with polycythemia vera, the prognostic factors including leukocytosis were examined in the context of outcomes such as the development of leukemic or fibrotic transformation, thrombosis and overall survival. -
Managing Epidermal Growth Factor Receptor Inhibitor-Associated Skin Reactions
Epidermal Growth Factor Receptor Inhibitors have proven to be effective cancer therapy for selected conditions, but skin toxicity is common. -
Pharmacology Watch
SSRIs are associated with a low rate of birth defects according to 2 new studies in the New England Journal of Medicine. SSRIs are often taken by women in their childbearing years, but the risk of birth defects has been unclear. -
Clinical Briefs in Primary Care Supplement